AQUA BIO TECHNOLOGY ASA - REGISTRATION OF SHARE CAPITAL INCREASE
January 16 2019 - 8:54AM
Technology ASA (the "Company") regarding, inter alia, a share capital
reduction and a private placement towards the Company's 140 largest
shareholders and members of the Board of Directors and management
(the "Private Placement"). Reference is
furthermore made to the stock exchange announcement on 7 January
2019 regarding the general meeting`s resolution on, inter alia, the share capital decrease and the Private
Placement.
The share capital changes has now been registered
with the Norwegian Register of Business Enterprises. The new share
capital is NOK 29,094,995 divided on 11,637,998 shares, each with a
par value of NOK 2.50. The new shares will be listed and become
tradable on Oslo Axess after approval and publication of a listing
prospectus, which is expected to occur during February 2019.
For further information, please call Arvid
Lindberg, Head of Sales & Marketing, telephone +47 98245410 or
arvid@aquabiotech.no.
Aqua Bio Technology (ABT) is developing and
commercializing sustainable biotechnology for use in skin care
products. ABT's cosmetics ingredients are highly effective and they
provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers
and professional users. Aqua Bio Technology is listed on the Axess
market of the Oslo Stock Exchange.
This information is subject
to the disclosure requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Aqua Bio Technology via Globenewswire
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Sep 2023 to Sep 2024